CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment is a research paper published in eLife (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI154722
NIAID NIH HHS
Grant: R01 AI138797
NIDDK NIH HHS
Grant: R01 DK119937
National Institutes of Health
Grant: 5R01AI154722-03
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
OncoC4, Inc
Fields of Study
MeSH Terms
Keywords